Annual EBITDA
-$32.48 M
-$18.58 M-133.71%
31 December 2023
Summary:
Forte Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$32.48 million, with the most recent change of -$18.58 million (-133.71%) on 31 December 2023. During the last 3 years, it has fallen by -$18.31 million (-129.18%). FBRX annual EBITDA is now -133.71% below its all-time high of -$13.90 million, reached on 31 December 2022.FBRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$8.62 M
+$4.19 M+32.71%
30 September 2024
Summary:
Forte Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$8.62 million, with the most recent change of +$4.19 million (+32.71%) on 30 September 2024. Over the past year, it has increased by +$1.59 million (+15.61%). FBRX quarterly EBITDA is now -1270.27% below its all-time high of -$629.00 thousand, reached on 30 June 2019.FBRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$35.60 M
+$1.59 M+4.29%
30 September 2024
Summary:
Forte Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$35.60 million, with the most recent change of +$1.59 million (+4.29%) on 30 September 2024. Over the past year, it has dropped by -$4.56 million (-14.68%). FBRX TTM EBITDA is now -5559.30% below its all-time high of -$629.00 thousand, reached on 30 June 2019.FBRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBRX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -133.7% | +15.6% | -14.7% |
| 3 y3 years | -129.2% | -12.1% | -57.3% |
| 5 y5 years | - | -1160.1% | -2611.1% |
FBRX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -133.7% | at low | -242.8% | +32.7% | -190.4% | +4.3% |
| 5 y | 5 years | -133.7% | at low | -1160.1% | +32.7% | -2611.1% | +4.3% |
| alltime | all time | -133.7% | at low | -1270.3% | +32.7% | -5559.3% | +4.3% |
Forte Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.62 M(-32.7%) | -$35.60 M(-4.3%) |
| June 2024 | - | -$12.81 M(+64.3%) | -$37.19 M(+11.3%) |
| Mar 2024 | - | -$7.79 M(+22.3%) | -$33.42 M(+2.9%) |
| Dec 2023 | -$32.48 M(+133.7%) | -$6.38 M(-37.6%) | -$32.48 M(+4.6%) |
| Sept 2023 | - | -$10.21 M(+13.1%) | -$31.04 M(+28.0%) |
| June 2023 | - | -$9.03 M(+31.8%) | -$24.25 M(+33.0%) |
| Mar 2023 | - | -$6.86 M(+38.8%) | -$18.24 M(+31.2%) |
| Dec 2022 | -$13.90 M | -$4.94 M(+44.3%) | -$13.90 M(+13.4%) |
| Sept 2022 | - | -$3.42 M(+13.3%) | -$12.26 M(-25.8%) |
| June 2022 | - | -$3.02 M(+20.1%) | -$16.52 M(-14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.51 M(-23.8%) | -$19.24 M(-10.3%) |
| Dec 2021 | -$21.45 M(+51.4%) | -$3.30 M(-57.1%) | -$21.45 M(-5.2%) |
| Sept 2021 | - | -$7.69 M(+34.1%) | -$22.63 M(+13.5%) |
| June 2021 | - | -$5.73 M(+21.3%) | -$19.93 M(+18.1%) |
| Mar 2021 | - | -$4.73 M(+5.5%) | -$16.88 M(+19.1%) |
| Dec 2020 | -$14.17 M | -$4.48 M(-10.3%) | -$14.17 M(+46.2%) |
| Sept 2020 | - | -$5.00 M(+86.2%) | -$9.69 M(+80.1%) |
| June 2020 | - | -$2.68 M(+33.2%) | -$5.38 M(+61.7%) |
| Mar 2020 | - | -$2.01 M(+194.4%) | -$3.33 M(+153.4%) |
| Sept 2019 | - | -$684.00 K(+8.7%) | -$1.31 M(+108.7%) |
| June 2019 | - | -$629.00 K | -$629.00 K |
FAQ
- What is Forte Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Forte Biosciences?
- What is Forte Biosciences annual EBITDA year-on-year change?
- What is Forte Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Forte Biosciences?
- What is Forte Biosciences quarterly EBITDA year-on-year change?
- What is Forte Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Forte Biosciences?
- What is Forte Biosciences TTM EBITDA year-on-year change?
What is Forte Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of FBRX is -$32.48 M
What is the all time high annual EBITDA for Forte Biosciences?
Forte Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$13.90 M
What is Forte Biosciences annual EBITDA year-on-year change?
Over the past year, FBRX annual earnings before interest, taxes, depreciation & amortization has changed by -$18.58 M (-133.71%)
What is Forte Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of FBRX is -$8.62 M
What is the all time high quarterly EBITDA for Forte Biosciences?
Forte Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$629.00 K
What is Forte Biosciences quarterly EBITDA year-on-year change?
Over the past year, FBRX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.59 M (+15.61%)
What is Forte Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of FBRX is -$35.60 M
What is the all time high TTM EBITDA for Forte Biosciences?
Forte Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$629.00 K
What is Forte Biosciences TTM EBITDA year-on-year change?
Over the past year, FBRX TTM earnings before interest, taxes, depreciation & amortization has changed by -$4.56 M (-14.68%)